Sargent Suzanne
Institute of Liver Studies, King's College Hospital, London.
Br J Nurs. 2006;15(4):212-9. doi: 10.12968/bjon.2006.15.4.20547.
Over 3000 deaths from cirrhosis/chronic liver disease are reported in England and Wales each year. However, these figures may underestimate the true extent of liver-related mortality by between 30-60%. As more patients with advanced cirrhosis are being nursed outside of specialist centres, it is essential that health professionals are aware of the management of cirrhotic-related complications. Defined as fluid within the peritoneal cavity, ascites is one of the most frequent complications of cirrhosis, and is considered as the marker of the transition from compensated to decompensated liver disease. The development of ascites is associated with a poor quality of life, increased risk of infections, renal failure and poor long-term outcomes. In recent years, however, there have been several advances in the management of ascites. This article will discuss both the pathophysiology, and the current medical, surgical and nursing management of this condition.
在英格兰和威尔士,每年有超过3000人死于肝硬化/慢性肝病。然而,这些数字可能会使与肝脏相关的死亡率的真实程度低估30%至60%。随着越来越多晚期肝硬化患者在专科中心以外接受护理,医护人员了解肝硬化相关并发症的管理至关重要。腹水被定义为腹腔内的液体,是肝硬化最常见的并发症之一,被视为从代偿期肝病转变为失代偿期肝病的标志。腹水的出现与生活质量差、感染风险增加、肾衰竭以及长期预后不良有关。然而,近年来腹水的管理取得了一些进展。本文将讨论这种疾病的病理生理学以及当前的药物、手术和护理管理。